|
12.06.2014 22:41:00
|
Auxilium Pharmaceuticals, Inc. -- Moody's: Vogelxo approval is credit negative for Auxilium
New York, June 12, 2014 -- Moody's Investors Service commented that the FDA's recent approval of a new testosterone gel product is credit negative for Auxilium Pharmaceuticals, Inc., the manufacturer of Testim testosterone gel. The newly approved product is Vogelxo, a 1% testosterone gel manufactured by Upsher-Smith Laboratories, Inc.
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.